What are the recommended follow-up steps for treatment of invasive squamous cell carcinoma (SCC) of the right chest with negative resection margins, no lymphovascular or perineural invasion, and clear deep and peripheral margins?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

For a well-differentiated invasive squamous cell carcinoma on the right chest with negative margins and no lymphovascular or perineural invasion, follow-up should include regular skin examinations every 3-6 months for the first 2 years, then every 6-12 months for 3-5 years, as recommended by the most recent European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma 1.

Key Considerations

  • No additional surgical intervention is needed since the margins are adequate, generally considered sufficient when greater than 4 mm 2.
  • The patient should perform monthly self-examinations of the skin and lymph nodes, particularly checking the axillary and cervical regions for any enlargement.
  • Sun protection measures are essential, including daily use of broad-spectrum SPF 30+ sunscreen, protective clothing, and avoiding peak sun hours.
  • Patient education about warning signs of recurrence or new skin cancers is important.

Prognostic Factors

  • The favorable prognostic factors in this case include well-differentiated histology, absence of lymphovascular/perineural invasion, and adequate margins, which together suggest a low risk of recurrence 3, 4.
  • However, patients with one skin cancer have a higher risk of developing others, necessitating vigilant surveillance and preventive measures.

Follow-Up and Management

  • The frequency of follow-up visits and investigations for subsequent new cSCC depends on underlying risk characteristics, as outlined in the European consensus-based guideline 1.
  • Multidisciplinary board decisions are mandatory for all patients with advanced cSCC, considering the risks of toxicity, the age and frailty of patients, and co-morbidities, including immunosuppression.

Related Questions

What is the diagnosis and prognosis for a patient with a suspicious lesion on the right chest, where an excision was performed and pathology revealed invasive squamous cell carcinoma with negative resection margins, no lymphovascular or perineural invasion, and clear margins of 4mm deep and 5mm peripheral?
Is further follow-up needed for a patient with well-differentiated invasive squamous cell carcinoma (SCC) of the scalp, with negative margins of excision, beyond regular skin monitoring?
What is the recommended treatment for a 1.5 mm moderately differentiated invasive squamous cell carcinoma?
Is curettage and electrodesiccation suitable for treating well-differentiated squamous cell carcinoma on the leg?
What are the indications for adjuvant radiation therapy after radical cystectomy in bladder cancer?
Is aripiprazole (Abilify) or olanzapine (Zyprexa) more effective for managing irritability in older adults?
What percent increase occurs in maternal blood volume during pregnancy?
What is the diagnosis and prognosis for a patient with a suspicious lesion on the right chest, where an excision was performed and pathology revealed invasive squamous cell carcinoma with negative resection margins, no lymphovascular or perineural invasion, and clear margins of 4mm deep and 5mm peripheral?
Does ischemia on electrocardiogram (EKG) require emergency intervention?
What is the average blood loss from a laparoscopic cholecystectomy (surgical removal of the gallbladder using a minimally invasive technique) with an intraoperative cholangiogram (intraoperative imaging of the bile ducts)?
What is the diagnostic workup for Group B Coxsackievirus (Coxsackie B virus) infection?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.